Advanced Biomed Inc.
ADVB
$5.10
$0.357.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.75M | 1.82M | 1.68M | 1.73M | 1.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.65M | 2.70M | 2.58M | 2.58M | 2.07M |
| Operating Income | -2.65M | -2.70M | -2.58M | -2.58M | -2.07M |
| Income Before Tax | 5.42M | 4.72M | -2.87M | -2.74M | -2.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.42 | 4.72 | -2.87 | -2.74 | -2.85 |
| Earnings from Discontinued Operations | -144.30K | -330.70K | -514.80K | -514.80K | -514.80K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.28M | 4.39M | -3.38M | -3.26M | -3.37M |
| EBIT | -2.65M | -2.70M | -2.58M | -2.58M | -2.07M |
| EBITDA | -2.51M | -2.55M | -2.35M | -2.29M | -1.69M |
| EPS Basic | 4.95 | 3.98 | -3.27 | -3.17 | -3.33 |
| Normalized Basic EPS | -1.07 | -1.56 | -1.72 | -1.66 | -1.77 |
| EPS Diluted | 4.95 | 3.98 | -3.27 | -3.17 | -3.33 |
| Normalized Diluted EPS | -1.07 | -1.56 | -1.72 | -1.66 | -1.77 |
| Average Basic Shares Outstanding | 4.53M | 4.27M | 4.19M | 4.11M | 4.02M |
| Average Diluted Shares Outstanding | 4.53M | 4.27M | 4.19M | 4.11M | 4.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |